An EvoNexus Incubator Company
Biolinq develops skin-applied biosensors that analyze body fluid(s) to provide actionable health information that is normally only accessible using clinical grade equipment and settings. The Company’s first product is a minimally-invasive glucose sensing solution that provides real-time and continuous glucose measurement without the need to extract blood. Biolinq’s patent-pending biosensor technology was developed by leading researchers from UC San Diego’s Laboratory for NanoBioElectronics. Visit the website to learn more.